Necrolytic migratory erythema following prolonged continuous subcutaneous dasiglucagon administration: a rare dermatologic adverse event

Clinical management of congenital hyperinsulinism (CHI) remains a significant challenge due to its complex pathophysiology and the limitations of available therapies. Dasiglucagon, a synthetic glucagon analog, represents a novel approach to managing CHI, particularly in patients where conventional t...

Full description

Bibliographic Details

Published in:	Endocrinology, Diabetes & Metabolism Case Reports
Main Authors:	Lucas Weschle, Jenny Potratz, Frank Rutsch, Alexander Humberg, Sandra Oesingmann, Andreas Pascher, Alexander S Busch, Katja Masjosthusmann
Format:	Article
Language:	English
Published:	Bioscientifica 2025-04-01
Subjects:	necrolytic migratory erythema dasiglucagon congenital hyperinsulinism neonatal hypoglycemia
Online Access:	https://edm.bioscientifica.com/view/journals/edm/2025/2/EDM-25-0006.xml